Rhodia snaps up McIntyre Group
This article was originally published in The Rose Sheet
Executive Summary
Specialty chemicals dealer Rhodia has completed its acquisition of McIntyre Group, which specializes in manufacturing mild surfactants, cosmetic preservatives and enhanced proteins, among other ingredients targeted to skin- and hair-care brands, firm says March 2. Move extends Rhodia's reach into the personal cleansing market, particularly in the hair care segment, and allows further business development in the Asia-Pacific and Latin American regions, according to the release
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.